Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer software revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3, reflecting a page version update.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedUpdated the Study Details page with revised trial design and outcome measures. Expanded the Locations/Enrollment information.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.4.2 was added and the prior Revision: v3.4.1 notice was removed; the page now reflects the current revision status.SummaryDifference0.2%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.